<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in germinal-centre (GC) B cells can be prevented by treatment with anti-immunoglobulin (Ig) </plain></SENT>
<SENT sid="1" pm="."><plain>By contrast, susceptible group-I Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cells can be driven to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by anti-Ig </plain></SENT>
<SENT sid="2" pm="."><plain>The second-messenger pathways involved in the regulation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in GC B lymphocytes and in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines were studied using pharmacological <z:chebi fb="4" ids="48705">agonists</z:chebi> or inhibitors of intracellular calcium ([<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i) and protein kinase C (PKC) </plain></SENT>
<SENT sid="3" pm="."><plain>Anti-Ig was found to mobilize <z:chebi fb="0" ids="29108">Ca2+</z:chebi> in group-I cells </plain></SENT>
<SENT sid="4" pm="."><plain>Pre-incubation with the <z:chebi fb="0" ids="29108">Ca2+</z:chebi> <z:chebi fb="0" ids="38161">chelator</z:chebi> <z:chebi fb="0" ids="30740">EGTA</z:chebi> partially <z:mp ids='MP_0006043'>reduced apoptosis</z:mp> induced by anti-Ig or by <z:chebi fb="0" ids="29108">Ca2+</z:chebi> <z:chebi fb="0" ids="24869">ionophore</z:chebi> in group-I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells </plain></SENT>
<SENT sid="5" pm="."><plain>Activation of PKC with <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> reduced such Ca(2+)-driven programmed cell <z:hpo ids='HP_0011420'>death</z:hpo> (PCD) to control levels of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> in group-I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines could also be triggered by the kinase inhibitors <z:chebi fb="0" ids="15738">staurosporine</z:chebi> and <z:chebi fb="0" ids="38912">Ro-31-8220</z:chebi> at concentrations selective for PKC activity </plain></SENT>
<SENT sid="7" pm="."><plain>Expression of the bcl-2 protein in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> group-I cells following gene transfer affords protection from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by ionomycin or anti-Ig </plain></SENT>
<SENT sid="8" pm="."><plain>In the present study, bcl-2 was additionally found to protect from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> driven by <z:chebi fb="0" ids="15738">staurosporine</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain>The high levels of spontaneous <z:mpath ids='MPATH_3'>apoptosis</z:mpath> exhibited by <z:mpath ids='MPATH_458'>normal</z:mpath> GC B cells were reduced, but not abrogated, by co-culture with <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>These results indicate that, in group-I <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells, imbalance in the <z:chebi fb="0" ids="16749">phosphoinositide</z:chebi> pathway of signalling, in favour of [<z:chebi fb="0" ids="29108">Ca2+</z:chebi>]i and away from PKC, results in <z:mpath ids='MPATH_3'>apoptosis</z:mpath>: constitutive phosphorylation of key proteins by PKC may therefore suppress <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> as well as in GC B cells </plain></SENT>
</text></document>